Emerging infections
A satellite symposium organised by the International Society of Infectious Diseases discussed emerging infectious diseases in the time of Ebola. Giving the keynote lecture, Kevin De Cock (CDC, Nairobi, Kenya) described as the "greatest scandal" the lack of attention by the health and development community to improving sanitation as a means to prevent disease emergence. Talking on human and animal migration, Nina Marano (CDC, Nairobi, Kenya) proposed that the Middle East respiratory syndrome coronavirus had fi rst jumped from bats to camels in sub-Saharan Africa, and that camels carried the virus to the Middle East as part of an extensive livestock trade. Oyewale Tomori (Redeemer's University, Ibadan, Nigeria) was highly critical of Africa's unpreparedness for disease emergence, and of the role of African political leaders in failing to control the Ebola outbreak.
Clostridium diffi cile
Recurrent disease is common after initial treatment for Clostridium diffi cile infection. 
Urinary tract infections
Andreas Vente (poster L-1251; MerLion Pharmaceuticals, Berlin, Germany) presented results of a phase 2, randomised trial of fi nafl oxacin, a new fluoroquinolone antibiotic, in adult patients with complicated urinary tract infections or pyelonephritis. 226 patients were randomised to receive 800 mg intravenous or oral finafloxacin once daily for 5 or 10 days, or twice daily ciprofloxacin (400 mg intravenous or 500 mg oral) for 10 days. Clinical and microbiological test of cure measured on day 17 was 70% and 68% in the 5-day and 10-day fi nafl oxacin groups, respectively, and 57% in the 10-day ciprofl oxacin group. Compared with ciprofloxacin, the antimicrobial activity of finafloxacin was not reduced by acidic urine pH.
Infection control by personality
Lindsay Grayson (University of Melbourne, VIC, Australia) described research showing how infection prevention and control messages might be tailored to personality types of health-care workers (HCWs; poster S-409). Grayson and colleagues used the ColourGrid profi ling tool to assess personality differences among HCW categories at fi ve Australian hospitals. HCWs showed more individualism, lower power distance, less uncertainty avoidance, and greater cynicism about advertising messages than the general population. Outcomes varied among HCW types (doctors, nurses, etc) and between senior and junior doctors. The former are more like to respond to messages around evidence-based compliance, whereas messages for the latter should focus on leadership opportunity and career risk for nonadherence.
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ICAAC/ICC 2015
The 55th, and fi nal stand-alone, ICAAC took place on Sept 17-21, in collaboration with the International Congress of Chemotherapy. John McConnell reports from San Diego
